Document is current

Article History

Received: 11 June 2021

Accepted: 2 February 2022

First Online: 21 February 2022

Declarations

:

: Ethical approvals for study conduct were obtained from the Camberwell St Giles Research Ethics Committee (REC reference: 17/LO/1154), in London from the CEIC Fundacio Sant Joan de Deu (CI: PIC-128-17) in Barcelona, and from the Medische Ethische Toetsingscommissie VUms (METc VUmc registratienummer: 2018.012 – NL63557.029.17) in the Netherlands. RADAR-MDD was conducted per the Declaration of Helsinki and Good Clinical Practice, adhering to principles outlined in the NHS Research Governance Framework for Health and Social Care (2nd edition). All participants provided informed consent to participate.

: Not applicable.

: JCB and PA are full-time employees of H. Lundbeck A/S. DCM has accepted honoraria and consulting fees from Apple, Inc., Otsuka Pharmaceuticals, Pear Therapeutics, and the One Mind Foundation, royalties from Oxford Press, and has an ownership interest in Adaptive Health, Inc. NVM is an employee of Janssen Pharmaceutica NV and may hold company equity.QL, NM, SV and VN are employees of Janssen Research & Development, LLC and hold company stocks/stock options. JMH has received economic compensation for participating in advisory boards or giving educational lectures from Eli Lilly & Co, Sanofi, Lundbeck, and Otsuka. No other authors have competing interests to declare.